, opens new tab said on Monday it had discontinued an experimental combination treatment testing a new type of immunotherapy in patients with a severe form of skin cancer after side effects led to ...

Merck & Co. has bailed early on a phase 3 test of the anti-TIGIT antibody vibostolimab after a high rate of discontinuations rendered the trial's success unlikely. The Big Pharma had been ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a total of nearly $1 billion in their operations in ...

Magnesium combined with hydroxide or carbonate ions may help neutralize the acid in your stomach. These magnesium-containing products may give you short-term relief from acid reflux symptoms ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Merck &amp, Co has announced that phase 2 clinical trials of its investigational once-weekly DPP-4 inhibitor, in development for the treatment of type 2 diabetes, have been effective. The drug, MK ...

What is the 'other carbon dioxide problem'? How are humans driving changes in the chemistry of the ocean, and what might this mean for marine ecosystems in the future?